{"id":"https://openalex.org/W4256720199","doi":"https://doi.org/10.1097/tp.0000000000001749","title":"Research Highlights","display_name":"Research Highlights","publication_year":2017,"publication_date":"2017-04-22","ids":{"openalex":"https://openalex.org/W4256720199","doi":"https://doi.org/10.1097/tp.0000000000001749"},"language":"en","primary_location":{"id":"doi:10.1097/tp.0000000000001749","doi":"https://doi.org/10.1097/tp.0000000000001749","is_oa":false,"landing_page_url":"https://doi.org/10.1097/tp.0000000000001749","pdf_url":null,"source":{"id":"https://openalex.org/S11564597","display_name":"Transplantation","issn_l":"0041-1337","issn":["0041-1337","1534-6080"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071342347","display_name":"Elmi Muller","orcid":"https://orcid.org/0000-0003-4891-5296","observed_orcids":["https://orcid.org/0000-0003-4891-5296"]},"institutions":[{"id":"https://openalex.org/I2802258008","display_name":"Groote Schuur Hospital","ror":"https://ror.org/00c879s84","country_code":"ZA","type":"healthcare","lineage":["https://openalex.org/I1307091933","https://openalex.org/I2802258008"]}],"countries":["ZA"],"is_corresponding":true,"raw_author_name":"Elmi Muller","raw_affiliation_strings":["Elmi Muller, Groote Schuur Hospital, Main Road, Observatory, Cape Town, Western Cape, 7925, South Africa. ([email\u00a0protected])","Groote Schuur Hospital, Main Road, Observatory, Cape Town, Western Cape, South Africa","The author declares no conflicts of interest"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Elmi Muller, Groote Schuur Hospital, Main Road, Observatory, Cape Town, Western Cape, 7925, South Africa. ([email\u00a0protected])","institution_ids":["https://openalex.org/I2802258008"]},{"raw_affiliation_string":"Groote Schuur Hospital, Main Road, Observatory, Cape Town, Western Cape, South Africa","institution_ids":["https://openalex.org/I2802258008"]},{"raw_affiliation_string":"The author declares no conflicts of interest","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5071342347"],"corresponding_institution_ids":["https://openalex.org/I2802258008"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.43437291,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"101","issue":"5","first_page":"893","last_page":"893"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9909999966621399},{"id":"https://openalex.org/keywords/liver-transplantation","display_name":"liver transplantation","score":0.9869999885559082},{"id":"https://openalex.org/keywords/tumor-recurrence","display_name":"tumor recurrence","score":0.9290000200271606},{"id":"https://openalex.org/keywords/neutrophil-to-lymphocyte-ratio","display_name":"neutrophil-to-lymphocyte ratio","score":0.8610000014305115},{"id":"https://openalex.org/keywords/alpha-fetoprotein","display_name":"alpha-fetoprotein","score":1.0},{"id":"https://openalex.org/keywords/milan-criteria","display_name":"Milan criteria","score":0.843999981880188},{"id":"https://openalex.org/keywords/recurrence-risk-stratification","display_name":"recurrence risk stratification","score":0.7490000128746033},{"id":"https://openalex.org/keywords/recurrence-free-survival","display_name":"recurrence-free survival","score":0.781000018119812},{"id":"https://openalex.org/keywords/tumor-size","display_name":"tumor size","score":0.656000018119812},{"id":"https://openalex.org/keywords/vascular-invasion","display_name":"vascular invasion","score":0.9679999947547913},{"id":"https://openalex.org/keywords/tumor-grade","display_name":"tumor grade","score":0.6010000109672546},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7080000042915344},{"id":"https://openalex.org/keywords/post-transplant-monitoring","display_name":"post-transplant monitoring","score":0.5350000262260437}],"concepts":[{"id":"https://openalex.org/C2779609443","wikidata":"https://www.wikidata.org/wiki/Q1368191","display_name":"Liver transplantation","level":3,"score":0.8039848804473877},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.7990657687187195},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7616382241249084},{"id":"https://openalex.org/C2776282453","wikidata":"https://www.wikidata.org/wiki/Q1352293","display_name":"Milan criteria","level":4,"score":0.673248291015625},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6582168936729431},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5751876831054688},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5554253458976746},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.47752702236175537},{"id":"https://openalex.org/C2780624289","wikidata":"https://www.wikidata.org/wiki/Q306076","display_name":"Alpha-fetoprotein","level":3,"score":0.46051302552223206},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.44808781147003174}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/tp.0000000000001749","doi":"https://doi.org/10.1097/tp.0000000000001749","is_oa":false,"landing_page_url":"https://doi.org/10.1097/tp.0000000000001749","pdf_url":null,"source":{"id":"https://openalex.org/S11564597","display_name":"Transplantation","issn_l":"0041-1337","issn":["0041-1337","1534-6080"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2516740959","https://openalex.org/W3004944370","https://openalex.org/W7125676888","https://openalex.org/W3180147542","https://openalex.org/W2939866337","https://openalex.org/W4404277490","https://openalex.org/W4401433673","https://openalex.org/W4283080597","https://openalex.org/W4386097452","https://openalex.org/W7213878326"],"abstract_inverted_index":{"Recurrence":[0],"After":[1],"Liver":[2],"Transplantation":[3],"for":[4,30,86,106,231,252,283,313,339,344,356,383],"Hepatocellular":[5],"Carcinoma:":[6],"A":[7,316],"New":[8],"MORAL":[9],"to":[10,178,326,427,529,566,629,632],"the":[11,31,63,77,102,121,126,167,216,232,277,284,290,295,300,306,413,417,423,434,440,443,473,518,537,540,562,576,619,644],"Story":[12],"Halazun":[13],"KJ,":[14],"Najjar":[15],"M,":[16],"Abdelmessih":[17],"RM,":[18],"et":[19,370],"al.":[20,371],"Ann":[21],"Surg.":[22],"2017;265(3):557\u2013564.":[23],"The":[24,158,420,478,558],"Milan":[25,327],"criteria":[26,45,328],"are":[27,46],"traditionally":[28],"used":[29,382],"indication":[32],"of":[33,160,181,187,226,318,416,425,442,461,476,490,499,507,522,542,564,578,612,638,647],"liver":[34,84],"transplantation":[35,85],"in":[36,94,165,202,215,289,294,299,305,329,439,481,483,497,517,553,575,581,655],"patients":[37,81,346,456],"with":[38,73,154,229,386,450,457,504,602,624],"hepatocellular":[39],"carcinoma":[40],"(HCC)":[41],"requiring.":[42],"However,":[43],"these":[44,161],"based":[47,183,275],"on":[48,99,129,184,276,570],"radiological":[49],"findings":[50],"and":[51,67,76,91,111,144,194,211,264,303,320,332,342,348,395,411,549,594,640],"provide":[52],"therefore":[53],"very":[54,196,307],"little":[55],"insight":[56],"into":[57],"tumor":[58,146],"biology.":[59],"Biological":[60],"markers":[61],"including":[62,391,539],"neutrophil-lymphocyte":[64],"ratio":[65],"(NLR)":[66],"alpha-fetoprotein":[68],"(AFP)":[69],"have":[70,323],"been":[71,324],"associated":[72,153,385],"HCC":[74,87,345],"recurrence":[75,156,182,341],"authors":[78,103,168,479,538,559],"investigated":[79,535],"339":[80],"who":[82,115],"underwent":[83],"between":[88],"January":[89],"2001":[90],"December":[92],"2012":[93],"a":[95,130,145,170,195,222,335,376,402,458,554,582,595,603,609,656],"single":[96],"center.":[97],"Based":[98,128],"their":[100,179],"analysis,":[101,134],"formulated":[104],"thresholds":[105],"NLR":[107,136],"(>":[108],"than":[109,138,142,149,261,267],"5)":[110],"AFP":[112,140],"(>200).":[113],"Patients":[114,173,214,269],"died":[116],"within":[117],"90":[118],"days":[119],"after":[120],"transplant":[122],"were":[123,152,174,270,534],"excluded":[124],"from":[125],"study.":[127],"multivariable":[131],"Cox":[132],"regression":[133],"an":[135,463],"greater":[137,141,148,260,266],"5,":[139],"200,":[143],"size":[147,259],"3":[150,162,262],"cm":[151,263],"higher":[155,459],"rates.":[157],"combination":[159,317],"factors":[163,251],"resulted":[164],"what":[166],"call,":[169],"Pre-MORAL":[171,218],"score.":[172,279],"then":[175,588],"stratified":[176,274],"according":[177],"risk":[180,219,234,250,273],"pre-MORAL":[185],"scores":[186],"low":[188,233],"(0-2),":[189],"medium":[190],"(3-6),":[191],"high":[192,604],"(7-10),":[193],"high-risk":[197,301,308],"group":[198,220,235,309],"(>10).":[199],"Recurrence-free":[200],"survival":[201,225,282],"all":[203,314],"4":[204,246,255,285],"groups":[205,286],"was":[206,243,287,622,627],"compared":[207,228],"using":[208,245,614],"Kaplan-Meier":[209],"curves":[210],"log-rank":[212],"testing.":[213],"highest":[217],"had":[221],"5-year":[223],"recurrence-free":[224,281],"17.9%":[227],"98.6%":[230],"(P":[236,310],"<":[237,311],"0.0001).":[238],"An":[239],"additional":[240],"post-MORAL":[241,278,321],"score":[242,322],"constructed":[244],"postoperatively":[247],"available":[248],"independent":[249,649],"recurrence:":[253],"grade":[254],"HCCs,":[256],"vascular":[257],"invasion,":[258],"number":[265],"3.":[268],"once":[271],"again":[272],"Five-year":[280],"97.4%":[288],"low-risk":[291],"group,":[292,297,302],"75.1%":[293],"medium-risk":[296],"49.9%":[298],"22.1%":[304],"0.05":[312],"comparisons).":[315],"pre-":[319],"superior":[325],"this":[330],"study":[331],"may":[333],"represent":[334],"highly":[336],"accurate":[337],"tool":[338],"predicting":[340],"risk-stratification":[343],"pretransplant":[347],"posttransplant.":[349],"Incomplete":[350],"Inhibition":[351],"by":[352,433,536],"Eculizumab:":[353],"Mechanistic":[354],"Evidence":[355],"Residual":[357],"C5":[358,426,436,448,495,508,524,544,590,601,650],"Activity":[359],"During":[360],"Strong":[361],"Complement":[362],"Activation":[363],"Harder":[364],"MJ,":[365],"Kuhn":[366],"N,":[367],"Schrezenmeier":[368],"H,":[369],"Blood.":[372],"2017;129(8):":[373],"970\u20139801":[374],"Eculizumab,":[375],"commercial":[377],"C5-blocking":[378],"antibody,":[379],"is":[380,401,452,470],"effectively":[381],"diseases":[384],"overly":[387],"active":[388],"complement":[389,418,445,501],"activation":[390,511],"paroxysmal":[392],"nocturnal":[393],"hemoglobinuria":[394],"atypical":[396],"hemolytic":[397],"uremic":[398],"syndrome.":[399],"Eculizumab":[400],"recombinant":[403],"humanized":[404],"monoclonal":[405],"IgG2/4":[406],"antibody":[407,571,621],"that":[408,486,643],"selectively":[409],"targets":[410],"inhibits":[412,422],"terminal":[414,444,466],"portion":[415],"cascade.":[419],"agent":[421],"cleavage":[424],"C5a":[428],"as":[429,431,547,606,608],"well":[430,607],"C5b":[432],"enzyme":[435],"convertase,":[437],"resulting":[438,552],"prevention":[441],"complex":[446],"C5b-9.":[447],"inhibition":[449,637],"eculizumab":[451,491,548,565,593,639],"not":[453,493],"absolute.":[454],"In":[455],"production":[460],"C3b":[462],"augmented":[464],"residual":[465,523,532],"pathway":[467],"(TP)":[468],"activity":[469,496,533,569,654],"observed,":[471],"limiting":[472],"therapeutic":[474],"benefit":[475],"eculizumab.":[477],"showed":[480],"several":[482],"vivo":[484],"models":[485],"even":[487],"excess":[488],"amounts":[489],"could":[492],"prevent":[494],"situations":[498],"strong":[500],"activation.":[502],"Even":[503],"maximum":[505],"blockage":[506],"activity,":[509],"TP":[510,568,653],"products":[512],"might":[513],"still":[514],"be":[515],"detectable":[516],"patients'":[519],"blood":[520],"because":[521],"activity.":[525],"Interesting":[526],"future":[527],"concepts":[528],"circumvent":[530],"such":[531,546],"application":[541],"different":[543],"inhibitors,":[545],"PAS-coversin,":[550],"potentially":[551],"better":[555],"clinical":[556],"response.":[557],"also":[560],"tested":[561],"capacity":[563],"inhibit":[567],"sensitized":[572],"sheep":[573],"erythrocytes":[574],"presence":[577],"human":[579],"serum":[580],"common":[583],"CP-mediated":[584],"hemolysis":[585,626],"assay.":[586],"They":[587],"included":[589],"inhibitory":[591],"agents":[592],"17-kDa":[596],"protein":[597],"coversin,":[598,641],"which":[599],"binds":[600],"affinity":[605],"modified":[610],"version":[611],"coversin":[613],"PASylation":[615],"called":[616],"PAS-coversin.":[617],"When":[618],"anti-C5":[620],"combined":[623],"eculizumab,":[625],"inhibited":[628],"levels":[630],"similar":[631],"those":[633],"seen":[634],"under":[635],"double":[636],"suggesting":[642],"synergistic":[645],"action":[646],"two":[648],"inhibitors":[651],"reduced":[652],"much":[657],"more":[658],"effective":[659],"way.":[660]},"counts_by_year":[],"updated_date":"2026-07-30T17:31:21.811387","created_date":"2022-05-12T00:00:00"}